Startpage News
Startpage

News

18
SEP
2018

Implementing a collaborative project


Development and introduction of innovative methods in clinical practice for the diagnosis and treatment of malignant tumours using molecularly targeted radionuclides produced in Latvia

Institute of Chemical Physics at University of Latvia in collaboration with Radiopharmacy laboratory at "Kodolmedicīnas Klīnika, Ltd", Clinic of Therapeutic Radiology and Medical Physics at Riga East University hospital, Latvian Biomedical Research and Study Centre and Institute of Microbiology and Biotechnology at University of Latvia has initiated an interdisciplinary project "Development and introduction of innovative methods in clinical practice for the diagnosis and treatment of malignant tumors using molecularly targeted radionuclides produced in Latvia". The project activities are directed towards the achievement of two goals. First, the implementation of effective diagnostic techniques for neuroendocrine and prostate cancer patients by using radioactive compounds directed towards molecules expressed on the cancer cell surface - this will allow to identify precise localization of primary tumour and metastatic lesions and enable the development and implementation of a personalized radionuclide-based treatment plan. And second, the development of in vitro model systems that would be suitable for qualitative evaluation of the synthesized radionuclides to assess the efficacy of cancer cell targeting, therapy-induced biological effects as well as assess the possibilities to diminish expected side effects from this therapy.

Period: January 2018 - April 2019

Financing: Project support patron SIA "Mikrotīkls" and the donation is administered by the University of Latvia Foundation

Quick links



Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".